These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4068726)

  • 21. [Hemodynamic effects of ARL 115 in left ventricular insufficiency].
    Drobinski G; Komajda M; Lechat P
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):475-9. PubMed ID: 6508198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of the negative inotropic effects of metoprolol at short cycle lengths in humans: comparison with sotalol and verapamil.
    Ritchie RH; Zeitz CJ; Wuttke RD; Hii JT; Horowitz JD
    J Am Coll Cardiol; 2006 Sep; 48(6):1234-41. PubMed ID: 16979012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease.
    van den Brand M; Serruys P; de Roon Y; Aymard MF; Dufour A
    Eur J Clin Pharmacol; 1984; 26(3):297-302. PubMed ID: 6734691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cibenzoline attenuates coronary systolic reversal flow in a patient with hypertrophic obstructive cardiomyopathy: a case report.
    Saihara K; Hamasaki S; Otsuji Y; Yoshitama T; Ishida S; Kataoka T; Okui H; Tei C
    J Cardiol; 2006 Oct; 48(4):209-13. PubMed ID: 17066624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic effects of the association of nifedipine and acebutolol].
    Monassier JP; Coulbois PM; Doll JW; Weiss JB; Basch B; Monassier C
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):317-23. PubMed ID: 6807248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamic effects of percutaneous trinitrin].
    Page A; Ledain L; Gateau P; Besse P
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):453-61. PubMed ID: 6786243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the Na+ antagonist cibenzoline on left ventricular function of postischemic hearts.
    Hoffmeister HM; Beyer ME; Seipel L
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):351-7. PubMed ID: 7662603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic effects of various doses of a new inotropic: amrinoma].
    Cárdenas M; Vidaurri A
    Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.
    Remme WJ; van Hoogenhuyze DC
    Cardioscience; 1990 Sep; 1(3):169-76. PubMed ID: 2102806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol.
    Brüssel T; Theissen JL; Vigfusson G; Lunkenheimer PP; Van Aken H; Lawin P
    Anesth Analg; 1989 Jul; 69(1):35-40. PubMed ID: 2787130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cibenzoline].
    Touboul P
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():91-4. PubMed ID: 3938265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic assessment of amrinone. A new inotropic agent.
    Benotti JR; Grossman W; Braunwald E; Davolos DD; Alousi AA
    N Engl J Med; 1978 Dec; 299(25):1373-7. PubMed ID: 714115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM; Presant S; Morissette M
    Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effects of verapamil and practolol in man.
    Seabra-Gomes R; Rickards A; Sutton R
    Eur J Cardiol; 1976 Mar; 4(1):79-85. PubMed ID: 1261583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs.
    Josephson MA; Singh BN
    Angiology; 1986 Dec; 37(12 Pt 2):950-8. PubMed ID: 2433969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.